Post-approval studies (Phase 4)Ended earlyNCT02213653
What this trial is testing
Randomized Study Evaluating Agents Stimulants Erythropoiesis (ASE) Associated With Ferric Carboxymaltose (Ferinject ®) in Concomitant or Sequential Patients Treated for Cancer and With Anemia Associated With Functional Iron Deficiency
Who this might be right for
Solid Cancer Metastatic DiseaseLymphoid Disease
Centre Francois Baclesse 24